102 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1652

Fusen Pharmaceutical
HK$1.000%-30.1%HK$739.3mn/aPS1.6xn/a0%

2142

HBM Holdings
HK$1.15-8.7%-22.8%HK$882.9mn/aPE5.1xn/an/a

950

Lee's Pharmaceutical Holdings
HK$1.16-1.7%-3.3%HK$706.6mn/aPE10.8xn/a2.6%

2509

Qyuns Therapeutics
HK$23.50-12.6%n/aHK$6.3bn/aPS78.8xn/an/a

6998

Genor Biopharma Holdings
HK$1.650%73.7%HK$851.7mn/aPS53xn/an/a

858

Extrawell Pharmaceutical Holdings
HK$0.032-3.0%-31.9%HK$78.9mn/aPS1.3xn/an/a

2181

Mabpharm
HK$0.338.2%-33.3%HK$1.4bn/aPS8.1xn/an/a

2552

Hua Medicine (Shanghai)
HK$1.183.5%-31.8%HK$1.2bHK$3.50PS9.6xn/an/a

1498

PuraPharm
HK$0.67-2.9%-40.7%HK$260.7mn/aPB2xn/a0%

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.31-2.2%0%HK$728.3mn/aPE3.9xn/a42.4%

1889

Sanai Health Industry Group
HK$0.23-4.6%-83.6%HK$35.0mn/aPE2.4xn/a0%

6622

Zhaoke Ophthalmology
HK$1.373.0%-59.2%HK$742.7mHK$7.68PS11.8xn/an/a

2161

JBM (Healthcare)
HK$0.945.6%-10.5%HK$761.8mn/aPE5.9xn/a8.6%

1558

YiChang HEC ChangJiang Pharmaceutical
HK$8.474.4%29.9%HK$7.3bHK$13.80PE4.1xS2.0%0%

1061

Essex Bio-Technology
HK$2.281.3%-19.1%HK$1.3bn/aPE4.9xn/a5.3%

719

Shandong Xinhua Pharmaceutical
HK$5.395.7%-2.7%HK$8.9bn/aPE6.7xn/a1.0%

2137

Brii Biosciences
HK$1.0411.8%-58.7%HK$767.5mn/aPS17.8xE-7.4%n/a

1643

Modern Chinese Medicine Group
HK$0.32-1.6%-21.3%HK$186.0mn/aPE11.9xn/a0%

575

Regent Pacific Group
HK$0.40-9.1%-57.9%HK$102.8mn/aPS48.7xn/an/a

503

Lansen Pharmaceutical Holdings
HK$1.790%23.6%HK$750.6mn/aPE13xn/a2.7%

1541

ImmuneOnco Biopharmaceuticals (Shanghai)
HK$4.85-14.3%-82.4%HK$1.8bHK$16.39PS220.1xS-82.4%n/a

1672

Ascletis Pharma
HK$1.03-1.9%-46.4%HK$993.1mHK$2.91PS91.3xE12.0%n/a

1011

China NT Pharma Group
HK$0.22-0.9%-76.9%HK$60.7mn/aPS1.6xn/a0%

1167

Jacobio Pharmaceuticals Group
HK$1.74-2.2%-46.3%HK$1.4bHK$3.70PS53.4xS-2.4%n/a
Page 3 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.